← Leaderboards
Kiran Solingapuram Sai
Wake Forest University Health Sciences
$5,408,657
Attributed
$10,309,321
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.4M · FY2020–25$10M$7.5M$5M$2.5M$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,309,321 · 4
By mechanism
RF1$6,424,607 · 1
R01$2,532,075 · 1
R56$926,389 · 1
R21$426,250 · 1
Top collaborators
- Mark G Baxter1 shared
- Suzanne Craft1 shared
- Akiva Mintz1 shared
- Carol A. Shively1 shared
Most similar at Wake Forest University Health Sciences
Same institution · by research overlap
- Waldemar Debinski$13,953,944
- Christopher T Whitlow$19,734,554
- Suzanne Craft$45,089,134
- Carol A. Shively$17,339,095
- Akiva Mintz$4,117,065
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposS DiseaseBrainImpairmentIn VivoPositron-Emission TomographyAmyloid Beta-ProteinNerve DegenerationMicrotubulesImageBiological MarkersPathogenesisClinical TrialsPathologicReportingFutureIn Vivo ImagingNeuroimagingCognitiveAutoradiographyImpaired CognitionAlzheimerâS Disease BiomarkerImaging StudyNeurons
Grant awards (8)
Moderation of Aging Trajectories of Cognition and Neuropathology by Diet Composition in Middle-aged Nonhuman Primates$6,424,607
RF1 · FY2025 · AG
Evaluating microtubule binding as a potential imaging biomarker for Alzheimer's disease$537,570
R01 · FY2024 · AG · contact PI
Developing novel PET radioligands to image GPR39 in Alzheimer's Disease$426,250
R21 · FY2024 · AG · contact PI
PET imaging of microtubules in cognitively normal and impaired older adults$926,389
R56 · FY2023 · AG · contact PI
Evaluating microtubule binding as a potential imaging biomarker for Alzheimer's disease$475,570
R01 · FY2023 · AG · contact PI
Evaluating microtubule binding as a potential imaging biomarker for Alzheimer's disease$483,320
R01 · FY2022 · AG · contact PI
Evaluating microtubule binding as a potential imaging biomarker for Alzheimer's disease$536,020
R01 · FY2021 · AG · contact PI
Evaluating microtubule binding as a potential imaging biomarker for Alzheimer's disease$499,595
R01 · FY2020 · AG · contact PI